Key result
Cardiotoxicity from treatments like anthracyclines, radiation, and trastuzumab is a significant concern for breast cancer survivors needing careful monitoring.
Population
Breast cancer survivors
Design
Review
Authors
Loading...
Supports cardiac monitoring in breast cancer survivors on cardiotoxic therapies; leaves open optimal protocols pending prospective data.
This review summarizes the cardiotoxic effects of various breast cancer treatments and discusses guidelines for monitoring cardiac function in these patients.
Bird et al. (2008) studied this question. Cardiotoxicity from treatments like anthracyclines, radiation, and trastuzumab is a significant concern for breast cancer survivors needing careful monitoring.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: